# B3GAT2

## Overview
B3GAT2 is a gene that encodes the enzyme beta-1,3-glucuronyltransferase 2, a member of the glucuronyltransferase family. This enzyme plays a pivotal role in the biosynthesis of glycosaminoglycans (GAGs) and the formation of proteoglycans, which are vital components of the extracellular matrix involved in cell signaling, adhesion, and tissue structure maintenance (Rühle2017Rare). Beta-1,3-glucuronyltransferase 2 is primarily expressed in neuronal tissues and is crucial for the synthesis of the HNK-1 carbohydrate epitope, a structure important for cell-cell interactions and neural development (Huang2021Global). The gene's expression and function have been linked to various clinical conditions, including pediatric venous thromboembolism and cancer, highlighting its significance in both normal physiological processes and disease pathogenesis (Yu2015Methylated; Rühle2017Rare).

## Function
The B3GAT2 gene encodes the enzyme beta-1,3-glucuronyltransferase 2, which is a member of the glucuronyltransferase family. This enzyme is involved in the biosynthesis of glycosaminoglycans (GAGs) and plays a crucial role in the formation of proteoglycans. Proteoglycans are essential components of the extracellular matrix and are involved in cell signaling, adhesion, and maintaining tissue structure (Rühle2017Rare). B3GAT2 is primarily expressed in neuronal tissues and is involved in the initial steps of proteoglycan synthesis, including the synthesis of the HNK-1 carbohydrate epitope (Huang2021Global). The enzyme catalyzes the transfer of glucuronic acid to glycoproteins, which is a critical step in the formation of the HNK-1 epitope, a carbohydrate structure involved in cell-cell interactions and neural development (Huang2021Global).

The expression of B3GAT2 is relatively low in certain cell types, such as HEK293 cells, which can lead to weak expression of the HNK-1 epitope. However, overexpression of related enzymes can enhance the production of glycans with HNK-1, indicating the importance of B3GAT2 in glycosylation pathways (Huang2021Global).

## Clinical Significance
The B3GAT2 gene has been implicated in several clinical conditions due to its genetic variants and altered expression levels. Rare genetic variants in B3GAT2 have been associated with pediatric venous thromboembolism (VTE). A genome-wide association study identified significant associations between specific single nucleotide polymorphisms (SNPs) in B3GAT2 and pediatric VTE, suggesting that these genetic variations may contribute to the condition's pathogenesis (Rühle2017Rare). 

In the context of cancer, B3GAT2 has been identified as a potential biomarker for Barrett's esophagus (BE), a precursor to esophageal adenocarcinoma. Studies have shown that B3GAT2 is aberrantly methylated in BE, indicating its potential role in the early detection of this condition (Yu2015Methylated). 

Additionally, B3GAT2 is involved in polysaccharide biosynthesis and metabolism, which has been linked to cancer progression, particularly in prostate cancer. This involvement suggests that alterations in B3GAT2 expression may influence cancer development and progression (Kim2023OGT). These findings highlight the clinical significance of B3GAT2 in various diseases, although the exact mechanisms remain to be fully elucidated.

## Interactions



## References


[1. (Yu2015Methylated) Ming Yu, Rachele M. O’Leary, Andrew M. Kaz, Shelli M. Morris, Kelly T. Carter, Amitabh Chak, Apoorva Chandar, Joseph E. Willis, Helen R. Moinova, Sanford D. Markowitz, Dean E. Brenner, Sharmila Anandabapasathy, Maria Westerhoff, Chao-Jen Wong, Nicholas J. Shaheen, Yanwen Chen, Jill S. Barnholtz-Sloan, and William M. Grady. Methylated b3gat2 and znf793 are potential detection biomarkers for barrett’s esophagus. Cancer Epidemiology, Biomarkers &amp; Prevention, 24(12):1890–1897, December 2015. URL: http://dx.doi.org/10.1158/1055-9965.epi-15-0370, doi:10.1158/1055-9965.epi-15-0370. This article has 12 citations.](https://doi.org/10.1158/1055-9965.epi-15-0370)

[2. (Huang2021Global) Yi-Fan Huang, Kazuhiro Aoki, Sachiko Akase, Mayumi Ishihara, Yi-Shi Liu, Ganglong Yang, Yasuhiko Kizuka, Shuji Mizumoto, Michael Tiemeyer, Xiao-Dong Gao, Kiyoko F. Aoki-Kinoshita, and Morihisa Fujita. Global mapping of glycosylation pathways in human-derived cells. Developmental Cell, 56(8):1195-1209.e7, April 2021. URL: http://dx.doi.org/10.1016/j.devcel.2021.02.023, doi:10.1016/j.devcel.2021.02.023. This article has 60 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.devcel.2021.02.023)

[3. (Kim2023OGT) Sung Han Kim, Jae Young Joung, Weon Seo Park, Jongkeun Park, Jin Seok Lee, Boram Park, and Dongwan Hong. Ogt and flad1 genes had significant prognostic roles in progressive pathogenesis in prostate cancer. The World Journal of Men’s Health, 41(3):712, 2023. URL: http://dx.doi.org/10.5534/wjmh.220231, doi:10.5534/wjmh.220231. This article has 1 citations.](https://doi.org/10.5534/wjmh.220231)

[4. (Rühle2017Rare) Frank Rühle, Anika Witten, Andrei Barysenka, Andreas Huge, Astrid Arning, Christine Heller, Anne Krümpel, Rolf Mesters, Andre Franke, Wolfgang Lieb, Mona Riemenschneider, Milan Hiersche, Verena Limperger, Ulrike Nowak-Göttl, and Monika Stoll. Rare genetic variants in smap1, b3gat2, and rims1 contribute to pediatric venous thromboembolism. Blood, 129(6):783–790, February 2017. URL: http://dx.doi.org/10.1182/blood-2016-07-728840, doi:10.1182/blood-2016-07-728840. This article has 16 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2016-07-728840)